Skip to main content
Premium Trial:

Request an Annual Quote

Steinmetz Joins Board Of Directors of Caliper


PALO ALTO, Calif.--Michael Steinmetz, managing director of the biotechnology venture capital firm Venture Asset Management, Cambridge, Mass., was elected to the board of directors of the bioinformation technology company Caliper Technologies here. Steinmetz also serves as acting CEO of the new, Munich-based, functional genomics company Genome Pharmaceuticals, and was previously vice-president of preclinical R&D for Hoffmann-LaRoche.

Caliper's chief product is the LabChip, a proprietary microfluidic bioprocessor technology that integrates microfabrication, electronics, software, biology, and chemistry, according to the company. Among LabChips' application are genomics and ultrahigh-throughput experimentation. Steinmetz predicted that the product "will revolutionize the generation and management of biochemical information."

David Lam, Caliper's president and CEO, said the company "will benefit greatly" from Steinmetz's "knowledge and experience in the biopharmaceutical industry and his track record of building strategic alliances." Steinmetz noted that the board appointment "continues a relationship I began with Caliper last year at Hoffmann-La Roche." Among Steinmetz's other accomplishments at the pharmaceutical company, he directed research alliances with such genomics companies as Millennium Pharmaceuticals and Incyte Pharmaceuticals.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.